Troubleshoot devices, get your questions answered and manage patient data with our easy-to-use service and support options. We offer extensive services, some of which are available 24/7. You’ll receive timely and high-quality support to ensure that your product works correctly, your patients are taken care of and your staff are trained to use all products effectively.
ALSO OF INTEREST
ZOLL announced today that the first patient has enrolled in the AMIHOT III post-approval study further evaluating TherOx® SuperSaturated Oxygen (SSO2) Therapy for the treatment of the most severe form of heart attack, left anterior descending (LAD) ST-Elevation Myocardial Infarction (STEMI)
ZOLL has been selected to exhibit SuperSaturated Oxygen (SSO2) Therapy, which delivers high levels of dissolved oxygen directly to the heart following a severe heart attack, at the Vizient Innovative Technology Exchange. Vizient, Inc – the nation’s largest member-driven health care performance improvement company – will hold the Exchange on 17 October in Dallas.
TherOx SuperSaturated Oxygen (SSO2) Therapy has been awarded a group purchasing agreement for Diagnostic and Interventional Cardiology Catheters (DIC) with Premier, Inc., effective as of 1 July 2022.
